In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against the other hot stocks. What’s the US Stock Market Like in 2025? While the stock market in the ...
Zai Lab (NASDAQ:ZLAB) announced Wednesday it would seek marketing approval for its cervical cancer therapy Tivdak (tisotumab vedotin) in China after patients who took part in the Chinese segment ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the China subpopulation of the global Phase 3 innovaTV 301 ...
In a report released on January 13, David Li from Bank of America Securities maintained a Buy rating on Zai Lab (ZLAB – Research Report), with a price target of $29.00. The company’s shares ...
Credit: Shutterstock / Phawat Chinese-American biopharmaceutical company Zai Lab has announced positive topline results from the China-specific arm in its Phase III innovaTV-301 study examining its ...
The FBI, working with French cops, obtained nine warrants to remotely wipe PlugX malware from thousands of Windows-based computers that had been infected by Chinese government-backed criminals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results